Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Relationship Between Cognition, Workforce Participation and Well-Being in Individuals With Multiple Sclerosis

Study ID: NCT07211516
Start Date: 2026-04
End Date: 2026-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment
Sponsor

Region Gävleborg

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study on the Safety and Efficacy of Tendon Stem Progenitor Cells Therapy for Rotator Cuff Tears

Study ID: NCT07320378
Start Date: 2026-05
End Date: 2029-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

107

Intervention / Treatment

Stem cell therapy

Conventional rotator cuff repair.

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Source: clinicaltrials.gov

Share:
Add to list

This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life Based on the Treatment Received in the Group of Patients Suffering From Malignant Lesions of the Head and Neck

Study ID: NCT07066878
Start Date: 2026-05-01
End Date: 2028-06-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

treatment received in the group of patients suffering from malignant lesions of the head and neck.

Sponsor

IRCCS San Raffaele

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Study ID: NCT07482943
Start Date: 2026-04
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

30

Intervention / Treatment

Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy

Sponsor

The University of Hong Kong

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of VER-01 in the Treatment of Patients With Radicular Chronic Low Back Pain

Study ID: NCT06956014
Start Date: 2026-09
End Date: 2027-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

810

Intervention / Treatment

VER-01

Placebo

Sponsor

Vertanical GmbH

Source: clinicaltrials.gov

Share:
Add to list

Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland

Study ID: NCT06426004
Start Date: 2026-04-01
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

660

Intervention / Treatment

patients will receive NPH education

primary care physicians (PCPs) will receive professional NPH education

A community health worker will assist PCP

Sponsor

Johns Hopkins Bloomberg School of Public Health

Source: clinicaltrials.gov

Share:
Add to list

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

Study ID: NCT06948084
Start Date: 2026-04-29
End Date: 2028-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Carfilzomib

Computed Tomography

Daratumumab and Recombinant Human Hyaluronidase

Dexamethasone

FDG-Positron Emission Tomography

Pomalidomide

Teclistamab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study

Study ID: NCT07376447
Start Date: 2026-05-31
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Thromboaspiration catheter

Sponsor

iVascular S.L.U.

Source: clinicaltrials.gov

Share:
Add to list

Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

Study ID: NCT07475949
Start Date: 2026-04
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

352

Intervention / Treatment

Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)

Standard medical treatment

Sponsor

First Affiliated Hospital of Guangxi Medical University

Source: clinicaltrials.gov

Share:
Add to list

Improving Cognitive Rehabilitation Outcomes

Study ID: NCT07055633
Start Date: 2026-04-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

144

Intervention / Treatment

CCT+MBLT

CCT+ION

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list